Just before “Treatment as Prevention” hit the headlines with some controversy, PrEP or Pre Exposure Prophylaxis, was on everybody’s lips.

PrEP is an experimental approach that would use antiretroviral medications (ARVs, which are normally used to treat people living with HIV) to reduce the risk of HIV infection in HIV-negative people. In this intervention, HIV-negative people would take a single drug or a combination of drugs with the hope that it would lower their risk of infection if exposed to HIV. PrEP trials are ongoing around the world. (Source: AVAC)

Whilst some …

Treatment as a means to prevent HIV infection has hit the media following a declaration by Brian Williams, professor of epidemiology at the South African Centre for Epidemiological Modelling and Analysis in Stellenbosch, at the AAAS in San Diego.
Whilst the HIV epidemic has shown some signs of stabilisation in the recent years, more than 7,000 people are still infected every day with the virus that causes AIDS.
Despite interesting results of a vaccine trial in Thailand, prevention is still limited to a small number of options many of which are not …

Lost Decade Gays

It used to be simple: there were the Gay ones and the Rest (though the Rest would have said that “there was us and the Gay guy next door”). But starting at the end of the “sleepy 50s” to climax by the end of the “Glorious 30s” (1945-1975), a sexual revolution had happened and had revealed a world of sexualities.
It was no coincidence that the “Lost Decade” (1980-1990) inaugurated by the abandon of state-led development policies in favour of Neo-liberalism was also the starting point of the tragic …

And would alternative policies deliver in the fight against HIV/AIDS?
This is what Rick Rowden, Senior Policy Analyst at ActionAid International USA, puts forward in his book “The Deadly Ideas of Neoliberalism: How the IMF has Undermined Public Health and the Fight Against AIDS”.

I have not read the book yet but went to the recent UK launch organised by the publisher Zed at the SOAS in London. I can only report on my first impressions about the thesis that IMF policies, by constraining and limiting health policies and budgets in poor …

The largest clinical trial of anti-retroviral therapy (ART) for people with HIV infection ever run in Africa has found that regular laboratory tests offer little additional clinical benefit to populations when compared to careful clinical monitoring.
The DART study was a controversial one that saw mislead and misleading activists trying to stop a study which outcome could contribute to save many lives.
The study published in The Lancet today concluded that “ART can be delivered safely without routine laboratory monitoring for toxic eff ects, but diff erences in disease progression suggest a …